Novo Nordisk Shares Tumble After Forecasted Sales Decline | Eli Lilly: Institutional Holdings, Insider Trading & Analyst Ratings | Novo Nordisk Shares Plunge After Cutting Full-Year Guidance | Eli Lilly Sales Soar on Weight Loss Drug Demand, Adjusts Profit Outlook | Novo Nordisk Stock Hits New Low Amid Analyst Disagreement and Legal Pressure | Novo Nordisk Shares Tumble After Forecasted Sales Decline | Eli Lilly: Institutional Holdings, Insider Trading & Analyst Ratings | Novo Nordisk Shares Plunge After Cutting Full-Year Guidance | Eli Lilly Sales Soar on Weight Loss Drug Demand, Adjusts Profit Outlook | Novo Nordisk Stock Hits New Low Amid Analyst Disagreement and Legal Pressure
Novo Nordisk (NVO) shares experienced a significant drop following the announcement of projected sales and profit declines for 2026. The pharmaceutical giant faces challenges including pricing pressures in the U.S. market and the expiration...
Image via CNBC
Novo Nordisk shares tumble 11% after company forecasts sales declines this year
